Maximus, Inc. (NYSE:MMS) Stock Holdings Increased by Rhumbline Advisers

Rhumbline Advisers boosted its position in Maximus, Inc. (NYSE:MMSFree Report) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 205,259 shares of the health services provider’s stock after buying an additional 11,772 shares during the quarter. Rhumbline Advisers owned approximately 0.34% of Maximus worth $15,323,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its stake in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank acquired a new position in Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC boosted its stake in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 180 shares during the period. R Squared Ltd acquired a new position in Maximus in the fourth quarter valued at approximately $54,000. Finally, Quarry LP boosted its stake in Maximus by 48.0% in the third quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock valued at $95,000 after acquiring an additional 330 shares during the period. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on MMS. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research note on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Check Out Our Latest Research Report on MMS

Insider Buying and Selling

In related news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now directly owns 6,567 shares in the company, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have bought a total of 7,063 shares of company stock valued at $502,017 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

Maximus Stock Performance

Shares of NYSE MMS opened at $65.95 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a 50 day simple moving average of $73.79 and a 200-day simple moving average of $81.67. The company has a market cap of $3.73 billion, a PE ratio of 14.18 and a beta of 0.72. Maximus, Inc. has a 12-month low of $64.53 and a 12-month high of $93.97.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.82%. Maximus’s dividend payout ratio is presently 25.81%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.